Fundamental Analysis
46 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.8% | +247.7% | 3 / 3 | -15.2% | -1.48 pp | +0.13 pp | +1.3% | 1.24 | 483.93 | 5.333 | −15,2% | 22,4 | +22,5% | 483.93 | 461.61 | +4,8% |
| Pts | 0 | 12 | 12 | 0 | 4 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 28.800 (close price on 2026-10-19)EPS (TTM): 59,5
Financial charts
1.Revenue & growth
VND bn5.333Q2/26
1.Revenue & growth
VND bn5.333Q2/26
2.Profit & growth
VND bn8,23Q2/26
3.Profit mix (Penman)
VND bn93,0Q2/26
4.Margins & cost structure
%9.7%Q2/26
5.Returns & cash cycle
% · days2.1%Q2/26
6.Earnings quality & cash
VND bn-223Q2/26
7.Asset structure
VND bn7.131Q2/26
8.Funding & debt health
VND bn · times7.131Q2/26
9.Revenue backlog
VND bn301Q2/26
10.Valuation
times · %483,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %16Q2/26
Adjusted EPS growth, latest quarter
2.8%
Average adjusted EPS growth, 3 quarters
361%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26